Stocks › IDXX
Idexx Laboratories Inc /De (IDXX) stock analysis
SKIP 9% confidence · analysed Nov 3, 2026
On Nov 3, 2026, our model rated Idexx Laboratories Inc /De (IDXX) SKIP with 9% confidence at a price of $672.04. That means the signals cancel out; the model sees no clear edge either way.
Technical picture
The 14-day RSI is 80, above 70, which is overbought: buyers have been very aggressive and a pause or pullback is common from here.
MACD is above its signal line, a sign that short-term momentum is turning up.
The price is above both its 50-day and 200-day moving averages, the classic picture of an uptrend.
Volume is 1.7x its 20-day average, so the latest move has real participation behind it.
Fundamentals
The PEG ratio is 3.67, which looks expensive relative to its growth.
The company reports a profit margin of 25.4% and revenue growth of +9.9%.
In its latest quarter it earned $4.01 per share, which beat the $3.71 analysts expected, with revenue +9.7% year over year.
Wall Street's average rating is 2.1 on a 1 (strong buy) to 5 (sell) scale, roughly a "buy", with an average price target of $705.92.
The next earnings report is expected around Feb 1, 2027; prices often move sharply around earnings.
The model's one-paragraph read
No clear edge (SKIP) — composite score +0.09 (SKIP). Technicals: RSI 79.64, MACD bullish, price above SMA50. Fundamentals: PEG 3.67, margin 25.4%, revenue growth 9.9%. Financial results: YoY revenue +9.7%, last EPS surprise +8.1%, next earnings 2027-02-01. FinGPT news read: positive. Reference price $672.04; no trade levels (SKIP).
Past ratings for IDXX
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Nov 3, 2026 | SKIP | 9% | $672.04 | — |
"Move since" compares each call's price with the latest analysed price.
Recent news on IDXX
- Nov 2, 2026: Review & Preview: Whiplash (Barrons.com)
- Nov 2, 2026: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day (MarketWatch)
- Nov 2, 2026: S&P 500 Movers: LITE, IDXX (Nasdaq)
- Nov 2, 2026: Nasdaq 100 Movers: LITE, IDXX (Nasdaq)
- Nov 2, 2026: Idexx Is Today's Best S&P 500 Stock. It's Defying an Industry Slump. (Barrons.com)
- Nov 2, 2026: IDEXX Raises Its Growth Outlook A Third Time As Diagnostics Volumes Outrun Falling Vet Visits, While CoVet Trims The Margin Guide (Earnings Whispers)
- Nov 2, 2026: IDEXX Laboratories Shares Rise 2.57% as Q3 Earnings Beat Forecasts and FY2026 Guidance Increases (InvestorsHub)
Frequently asked questions
Is IDXX a buy right now?
As of Nov 3, 2026, our automated model rates Idexx Laboratories Inc /De (IDXX) SKIP with 9% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does Idexx Laboratories Inc /De report earnings next?
The next earnings report is expected around Feb 1, 2027.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.